Class Actions Lawsuits
Product Liability

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action

Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action — Product Liability class action lawsuit

Case Overview

This class action litigation involves claims that GLP-1 receptor agonist drugs, including Ozempic and Wegovy manufactured by Novo Nordisk, are associated with non-arteritic anterior ischemic optic neuropathy (NAION), a condition characterized by sudden vision loss. Plaintiffs allege that the manufacturers failed to adequately warn consumers and healthcare providers about the risk of vision loss linked to these weight loss medications.

The lawsuit seeks compensation for individuals who have suffered vision loss or other serious complications after using these drugs. The case is currently being investigated and pursued by Weitz & Luxenberg, a nationwide mass torts law firm with offices in New York, New Jersey, Los Angeles, and Detroit. Eligible parties may include anyone who used Ozempic, Wegovy, or similar GLP-1 drugs and subsequently developed vision loss or NAION.

Who May Qualify

Individuals who took Ozempic, Wegovy, or other GLP-1 receptor agonist drugs and subsequently developed vision loss or non-arteritic anterior ischemic optic neuropathy (NAION)

Frequently Asked Questions

What is NAION and how is it connected to Ozempic?

NAION (non-arteritic anterior ischemic optic neuropathy) is a condition causing sudden vision loss. The lawsuit alleges that GLP-1 drugs like Ozempic and Wegovy increase the risk of developing NAION, and that manufacturers failed to adequately warn users about this potential side effect.

Am I eligible to join the Ozempic vision loss lawsuit?

You may be eligible if you used Ozempic, Wegovy, or similar GLP-1 drugs and subsequently experienced vision loss or were diagnosed with NAION. Contact a lawyer at Weitz & Luxenberg for a free case evaluation to determine your eligibility.

Can I sue for vision loss caused by these weight loss drugs?

Yes, ongoing class action litigation is being pursued against the manufacturers of these drugs. If you suffered vision loss after using these medications, you may have legal options to seek compensation for your injuries and medical expenses.

Related Cases

Jeep Hybrid SUV Misrepresentation Lawsuit — Product Liability class action lawsuit

Jeep Hybrid SUV Misrepresentation Lawsuit

Current
Product Liability
A group of Jeep owners filed a class action lawsuit alleging that FCA misrepresented the safety and reliability of their hybrid SUVs, specifically the Wrangler 4xe and Grand Cherokee 4xe. The lawsuit claims that FCA failed to properly disclose and repair significant defects in these vehicles, despite marketing them as safe and dependable. The plaintiffs allege that their reliance on FCA's representations led them to purchase or lease the vehicles, and they are seeking damages related to these alleged misrepresentations.
View Details
Graco Baby Swing Defect Class Action — Product Liability class action lawsuit

Graco Baby Swing Defect Class Action

Current
Product Liability
A class action lawsuit alleges that Graco's Slim Spaces Compact Baby Swing has a defect causing it to accelerate to dangerous speeds. The complaint claims this defect poses a serious risk of physical harm or death to infants.
View Details
Bell & Howell PFAS Cookware Class Action Settlement — Product Liability class action lawsuit

Bell & Howell PFAS Cookware Class Action Settlement

Past
Product Liability
This settlement addresses claims that cookware products from brands like Gotham Steel, Granite Stone, and Bell & Howell were falsely advertised as safe and non-toxic despite containing dangerous chemicals.
View Details